EVELYN SALDIVAR: Open Payments
NPI 1376177006 · MCALLEN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$723 in 27 payments from 9 companies in 2025. Trend: 2023 $1,319 · 2024 $2,255 · 2025 $723
Food & beverage: $723
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 11 | $200 |
| Novo Nordisk Inc | 6 | $197 |
| E.R. Squibb & Sons, L.L.C. | 1 | $114 |
| BIOTRONIK INC. | 1 | $64 |
| AstraZeneca Pharmaceuticals LP | 2 | $44 |
| Merck Sharp & Dohme LLC | 2 | $41 |
| Optinose US, Inc. | 2 | $28 |
| Medtronic, Inc. | 1 | $20 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $16 |
Products named: Kerendia, Wegovy, CAMZYOS, Acticor 7 VR-T DX, VERQUVO, LOKELMA, Xhance, VENASEAL.
Industry payments across TX — which companies pay providers there.
